GO:0023029 MHC class Ib protein binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0023029 (MHC class Ib protein binding) is a molecular function describing the selective binding of a protein to major histocompatibility complex class Ib molecules.
• Class Ib molecules such as HLA-E, HLA-F, HLA-G, H2-M3, Qa-1 and H2-M2 are non-classical MHC proteins with specialized peptide-binding and immune-receptor functions.
• Structural studies show that HLA-E binds a restricted peptide repertoire and engages NK-cell receptors such as NKG2A/CD94, making this binding function central to innate immune surveillance.
• H2-M3 is a mouse class Ib molecule that binds N-formylated peptides, illustrating how class Ib binding can recognize bacterial and mitochondrial signatures.
• Class Ib protein binding influences antigen-presenting cell maturation and immune tolerance, as shown in HLA-G transgenic models.
• CRISPR knockout, point-mutation, knock-in and overexpression models are powerful tools to dissect the causal role of class Ib binding in immunity and disease.
Description
GO:0023029, MHC class Ib protein binding, is a molecular function term that describes the binding of a protein to a major histocompatibility complex class Ib molecule. Class Ib molecules are non-classical MHC proteins that include human HLA-E, HLA-F and HLA-G, as well as mouse molecules such as H2-M3, Qa-1 (H2-T23), H2-T11 and H2-M2. Unlike classical MHC class Ia molecules, class Ib proteins often display limited polymorphism, restricted peptide repertoires and specialized roles in immune recognition. This binding function is therefore a focal point for understanding how innate and adaptive immune cells communicate with non-classical antigen-presentation systems. Researchers study MHC class Ib protein binding because it sits at the interface of peptide presentation, immune-receptor engagement and disease susceptibility. For example, HLA-E binds peptides derived from classical MHC class I signal sequences and interacts with NKG2A/CD94 receptors, thereby regulating natural killer cell activity. Mouse H2-M3 binds N-formylated peptides from bacteria and mitochondria, providing a model for detecting infection-associated ligands. In addition, HLA-G expression in transgenic mice compromises antigen-presenting cell maturation, linking class Ib binding to immune tolerance and maternal-fetal interface biology. These examples show that GO:0023029 is not a generic binding term but a biologically precise function with direct immunological consequences. Because class Ib molecules are less polymorphic than classical MHC proteins, they are attractive targets for mechanistic studies and therapeutic hypothesis testing. Modern CRISPR-based models allow researchers to knock out, mutate or tag class Ib genes and their binding partners, enabling causal tests of GO:0023029 in immune cells and disease models. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of MHC class Ib protein binding, its key genes, regulatory context, disease relevance and experimental methods.
MHC class Ib protein binding At A Glance
| GO ID | GO:0023029 |
|---|---|
| GO term | MHC class Ib protein binding |
| Ontology | molecular_function |
| Synonym | None listed in QuickGO |
| Major function | Binding to major histocompatibility complex class Ib molecules |
| Example class Ib molecules | HLA-E, HLA-F, HLA-G, H2-M3, Qa-1 (H2-T23), H2-T11, H2-M2 |
| Representative binding partners | NKG2A/CD94 receptors, peptide-loaded class Ib complexes |
| Biological context | Innate and adaptive immune recognition, antigen presentation, immune tolerance |
| Research relevance | Target for CRISPR knockout, point mutation, knock-in and overexpression studies |
What Is GO:0023029?
GO:0023029, MHC class Ib protein binding, is defined as the binding to a major histocompatibility complex class Ib molecule. In practical terms, it is the molecular interaction between a protein and a non-classical MHC class Ib protein such as HLA-E, HLA-F, HLA-G, H2-M3, Qa-1 or H2-M2. This function is distinct from binding to classical MHC class Ia molecules because class Ib proteins have specialized peptide-binding properties and often interact with innate immune receptors.
Why Is MHC class Ib protein binding Important in Cell Biology?
MHC class Ib protein binding is important because it governs how non-classical MHC molecules present specialized ligands and engage immune receptors, thereby shaping natural killer cell responses, T cell activation and immune tolerance. Dysregulation of these interactions has been linked to immune evasion, pregnancy complications and inflammatory conditions, making GO:0023029 a high-value function for both basic immunology and translational research.
• Class Ib molecules such as HLA-E regulate NK cell activity through receptor engagement, directly influencing innate immunity.
• HLA-E presents a restricted peptide repertoire, making its binding interactions highly specific and experimentally tractable.
• Mouse H2-M3 binds N-formylated peptides, providing a model for detecting bacterial and mitochondrial ligands.
• Qa-1 and H2-T11 share peptide-binding specificity, enabling comparative studies of class Ib function in mice.
• HLA-G expression affects antigen-presenting cell maturation, linking class Ib binding to immune tolerance.
• Class Ib molecules are less polymorphic than classical MHC proteins, simplifying functional dissection.
• GO:0023029 is relevant to cancer immunology because class Ib molecules can modulate anti-tumor immunity.
• CRISPR screens and targeted models can identify genes that regulate class Ib protein binding.
• Structural studies of HLA-E provide a template for understanding class Ib receptor interfaces.
• Class Ib binding functions are candidate biomarkers and therapeutic targets in immune-related diseases.
What Happens During MHC class Ib protein binding?
Peptide loading and class Ib complex formation
In simple terms: Class Ib molecules first pick up a peptide, and this peptide-loaded form is what other proteins bind to.
MHC class Ib molecules such as HLA-E assemble with a restricted set of peptides, often derived from classical MHC class I signal sequences, to form stable complexes. Recombinant random peptide approaches have shown that HLA-E has distinct peptide-binding characteristics compared with classical MHC molecules. In mice, H2-M3 binds N-formylated peptides, demonstrating that class Ib molecules can recognize chemically modified ligands. This peptide-loading step is a prerequisite for subsequent protein-protein interactions that define GO:0023029.
Receptor engagement by class Ib complexes
In simple terms: Once loaded with peptide, class Ib molecules bind to receptors on immune cells, transmitting signals.
Structural studies have revealed how HLA-E engages immune receptors such as NKG2A/CD94, providing a molecular basis for class Ib protein binding. These interactions allow class Ib molecules to deliver inhibitory or activating signals to natural killer cells and T cells. The binding specificity is determined by both the class Ib heavy chain and the bound peptide, making GO:0023029 a composite recognition function.
Class Ib-mediated immune modulation
In simple terms: By binding to receptors, class Ib molecules can turn immune responses up or down.
HLA-G transgenic mice show compromised maturation of antigen-presenting cells, indicating that class Ib protein binding can modulate immune cell development and tolerance. Similarly, HLA-E interactions with NKG2A regulate NK cell cytotoxicity and cytokine production. These outcomes illustrate how a single binding function can have broad immunological consequences.
Pathogen and tumor context
In simple terms: Infections and tumors can change how class Ib molecules are expressed and bound.
H2-M3 binding of N-formylated peptides allows detection of bacterial and mitochondrial proteins, linking class Ib function to infection surveillance. In cancer, class Ib molecules can influence anti-tumor immunity, and RAS(ON) multiselective inhibition has been shown to drive antitumor immunity in preclinical NRAS-mutant melanoma models. These contexts highlight the disease relevance of GO:0023029.
Key Genes Involved in GO:0023029 MHC class Ib protein binding
The following genes and proteins are central to MHC class Ib protein binding, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HLA-E | Human class Ib molecule that binds restricted peptides and engages NKG2A/CD94 | Model for class Ib peptide binding and NK cell regulation |
| HLA-F | Human class Ib molecule with specialized immune functions | Comparative studies of non-classical MHC function |
| HLA-G | Human class Ib molecule involved in immune tolerance | Transgenic models show effects on antigen-presenting cells |
| H2-M3 | Mouse class Ib molecule that binds N-formylated peptides | Model for bacterial and mitochondrial ligand recognition |
| H2-T23 (Qa-1) | Mouse class Ib molecule with shared peptide-binding specificity | Comparative studies with H2-T11 |
| H2-T11 | Mouse class Ib paralog of Qa-1 with shared peptide-binding specificity | Model for class Ib peptide repertoire studies |
| H2-M2 | Mouse class Ib gene encoding a conserved surface glycoprotein | Model for class Ib surface expression |
| NKG2A | Inhibitory receptor that binds HLA-E | Target for studying class Ib receptor engagement |
| CD94 | Partner of NKG2A in HLA-E recognition | Structural and functional studies of class Ib binding |
| B2M | Beta-2-microglobulin, light chain of MHC class I complexes | Required for class Ib surface expression |
| TAP1 | Peptide transporter supplying peptides to MHC class I | Affects peptide loading of class Ib molecules |
| TAP2 | Peptide transporter partner of TAP1 | Affects peptide loading of class Ib molecules |
| ERAP1 | Peptide trimming aminopeptidase | Modulates class Ib peptide repertoire |
| ERAP2 | Peptide trimming aminopeptidase | Modulates class Ib peptide repertoire |
| NRAS | Oncogene in melanoma; RAS inhibition drives antitumor immunity | Links class Ib immunity to cancer therapy |
| HLA-A | Classical MHC class I molecule providing signal-sequence peptides | Source of peptides for HLA-E |
| HLA-B | Classical MHC class I molecule providing signal-sequence peptides | Source of peptides for HLA-E |
How Is MHC class Ib protein binding Regulated?
MHC class Ib protein binding is regulated at multiple levels, including peptide availability, class Ib gene expression and receptor expression on immune cells. HLA-E surface levels depend on peptide loading and beta-2-microglobulin association, which are influenced by the peptide-processing machinery. In transgenic models, HLA-G expression alters antigen-presenting cell maturation, indicating that class Ib function can be regulated during immune cell differentiation. Additionally, tumor-intrinsic signaling such as RAS pathway activation can shape antitumor immunity, indirectly affecting class Ib-mediated interactions.
MHC class Ib protein binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HLA-E | Cancer immune evasion and NK cell regulation | Knockout or knock-in in NK cell lines |
| HLA-G | Immune tolerance and pregnancy complications | Transgenic mouse models |
| H2-M3 | Bacterial infection detection | Knockout mice and peptide-binding assays |
| NRAS | NRAS-mutant melanoma and antitumor immunity | CRISPR point mutation in melanoma cell lines |
| H2-T23 (Qa-1) | Class Ib peptide presentation | Knockout and overexpression models |
Cancer and immune evasion
Class Ib molecules such as HLA-E and HLA-G can modulate anti-tumor immunity by engaging inhibitory receptors on NK and T cells. In NRAS-mutant melanoma models, RAS(ON) multiselective inhibition drives antitumor immunity, highlighting the interplay between oncogenic signaling and class Ib-related immune recognition. These findings suggest that GO:0023029 is relevant to cancer immunotherapy strategies.
Immune tolerance and pregnancy
HLA-G is a class Ib molecule associated with immune tolerance, and HLA-G transgenic mice show compromised antigen-presenting cell maturation. This links class Ib protein binding to maternal-fetal interface biology and tolerance mechanisms. Dysregulation of these interactions may contribute to pregnancy complications, although further studies are needed.
Infection and innate immunity
H2-M3 binds N-formylated peptides from bacteria and mitochondria, enabling detection of infection-associated ligands. This demonstrates how class Ib protein binding contributes to innate immune surveillance. HLA-E also plays a role in NK cell responses during infection through NKG2A engagement.
From MHC class Ib protein binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of HLA-E affect NK cell cytotoxicity? | HLA-E knockout in NK cell lines or primary NK cells |
| How does H2-M3 peptide binding influence infection response? | H2-M3 knockout mice |
| Can HLA-G expression alter antigen-presenting cell maturation? | HLA-G transgenic mice |
| What is the peptide repertoire of H2-T11 versus Qa-1? | Knock-in or overexpression of H2-T11 in mouse cells |
| Does RAS inhibition enhance class Ib-mediated antitumor immunity? | NRAS-mutant melanoma models with CRISPR point mutation |
| How does HLA-E structure determine receptor engagement? | Point mutations in HLA-E followed by structural assays |
How to Study the MHC class Ib protein binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Recombinant peptide binding assay | Peptide affinity for class Ib molecules | Define HLA-E peptide repertoire |
| X-ray crystallography | Atomic structure of class Ib-receptor complexes | Map HLA-E/NKG2A interface |
| CRISPR knockout screening | Genes affecting class Ib expression or binding | Identify immune modulators |
| Flow cytometry | Surface class Ib levels and receptor binding | Phenotype transgenic models |
| Immunoprecipitation | Protein-protein interactions with class Ib | Detect binding partners |
| Transcriptomics (RNA-seq) | Expression of class Ib and related genes | Compare disease vs normal states |
| Proteomics | Peptide and protein composition of class Ib complexes | Identify bound peptides |
| Transgenic mouse models | In vivo effects of class Ib expression | Study immune tolerance |
Peptide-binding assays
Recombinant random peptide approaches and biochemical binding assays can define the peptide repertoire of class Ib molecules such as HLA-E. These methods measure direct binding affinity and specificity, providing quantitative data for GO:0023029.
Structural biology
X-ray crystallography and cryo-EM have revealed how HLA-E engages NKG2A/CD94, offering atomic-level insight into class Ib protein binding. Structural studies of H2-M3 with N-formylated peptides further illustrate ligand recognition.
CRISPR-based functional screens
CRISPR knockout and activation screens can identify genes that regulate class Ib surface expression and binding. These screens are particularly useful for discovering modifiers of GO:0023029 in immune cells.
Transgenic and knock-in models
HLA-G transgenic mice and H2-T11 knock-in models allow in vivo dissection of class Ib function. These models can be combined with flow cytometry and immune phenotyping to assess binding outcomes.
How CRISPR Can Be Used to Study GO:0023029 MHC class Ib protein binding
Knockout
CRISPR knockout of class Ib genes such as HLA-E or H2-M3 can abolish specific binding interactions, enabling loss-of-function studies. Knockout models are essential to test whether a candidate gene is required for GO:0023029.
Point Mutation
Point mutations in class Ib genes can disrupt specific residues involved in peptide or receptor binding, allowing fine mapping of interaction interfaces. For example, mutations in HLA-E can reveal determinants of NKG2A engagement.
Knock-in
Knock-in of human class Ib genes into mouse models, such as HLA-G transgenic mice, allows in vivo study of class Ib function. Similarly, H2-T11 knock-in can compare peptide-binding specificity with Qa-1.
Overexpression
Overexpression of class Ib molecules or their binding partners can enhance signal strength and reveal downstream effects on immune cell activation. This approach is useful for studying gain-of-function phenotypes in cancer and tolerance models.
How EDITGENE Supports MHC class Ib protein binding Research
Researchers studying MHC class Ib protein binding-related genes often need to determine whether a candidate gene is causally involved in immune recognition, tolerance or disease progression. EDITGENE provides CRISPR-based cell model services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for MHC class Ib protein binding research.
Frequently Asked Questions About MHC class Ib protein binding
What is MHC class Ib protein binding?
MHC class Ib protein binding (GO:0023029) is the molecular function of binding to a major histocompatibility complex class Ib molecule such as HLA-E, HLA-G or H2-M3.
What genes are involved in MHC class Ib protein binding?
Key genes include HLA-E, HLA-F, HLA-G, H2-M3, H2-T23 (Qa-1), H2-T11 and H2-M2.
What is the GO ID for MHC class Ib protein binding?
The GO ID is GO:0023029.
How does HLA-E bind peptides?
HLA-E binds a restricted peptide repertoire, often derived from classical MHC class I signal sequences, as shown by recombinant peptide studies.
What is the role of H2-M3 in immunity?
H2-M3 binds N-formylated peptides from bacteria and mitochondria, enabling detection of infection-associated ligands.
How is MHC class Ib protein binding studied?
It is studied using peptide-binding assays, structural biology, CRISPR screens and transgenic models.
What diseases are linked to MHC class Ib protein binding?
It is linked to cancer immune evasion, immune tolerance and infection responses.
Can CRISPR be used to study MHC class Ib protein binding?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models are widely used to dissect class Ib function.
What is the difference between MHC class Ia and class Ib?
Class Ib molecules such as HLA-E and HLA-G are less polymorphic and have specialized peptide-binding and immune-regulatory roles compared with classical class Ia molecules.
What model systems are available for class Ib research?
Available models include HLA-G transgenic mice, H2-M3 knockout mice and CRISPR-edited cell lines.
Conclusion
GO:0023029, MHC class Ib protein binding, is a specialized molecular function that underlies non-classical MHC biology, including peptide presentation, NK cell regulation and immune tolerance. Understanding this function requires integrating structural, biochemical and genetic approaches, with CRISPR models playing an increasingly central role. As research continues to link class Ib molecules to cancer, infection and tolerance, precise functional annotation and robust experimental models will remain essential.
References
- 1. Gillespie GM et al.. 2025. HLA-E: Immune Receptor Functional Mechanisms Revealed by Structural Studies.. Immunol Rev 329(1):e13434 PMID: 39753525
- 2. Anastacio Da Costa Carvalho L et al.. 2026. RAS(ON) Multiselective Inhibition Drives Antitumor Immunity in Preclinical Models of NRAS-Mutant Melanoma.. Cancer Immunol Res 14(1):90-106 PMID: 41186497
- 3. O'Callaghan CA et al.. 1998. Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G.. Immunol Rev 163:129-38 PMID: 9700506
- 4. Stevens J et al.. 2001. Peptide binding characteristics of the non-classical class Ib MHC molecule HLA-E assessed by a recombinant random peptide approach.. BMC Immunol 2:5 PMID: 11432755
- 5. Chen L et al.. 2014. Expression of the mouse MHC class Ib H2-T11 gene product, a paralog of H2-T23 (Qa-1) with shared peptide-binding specificity.. J Immunol 193(3):1427-39 PMID: 24958902
- 6. Wang CR et al.. 1995. Nonclassical binding of formylated peptide in crystal structure of the MHC class Ib molecule H2-M3.. Cell 82(4):655-64 PMID: 7664344
- 7. Moore YF et al.. 2004. Murine MHC class Ib gene, H2-M2, encodes a conserved surface-expressed glycoprotein.. Immunogenetics 56(1):1-11 PMID: 15045471
- 8. Horuzsko A et al.. 2001. Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice.. Int Immunol 13(3):385-94 PMID: 11222508
